{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T09:09:46Z","timestamp":1779527386348,"version":"3.53.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:00:00Z","timestamp":1774396800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:00:00Z","timestamp":1774396800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Ther"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s40744-026-00842-5","type":"journal-article","created":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T10:16:45Z","timestamp":1774433805000},"page":"691-699","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Diuretic-Induced Hypomagnesemia May Play a Key Role in the Development of Calcium Pyrophosphate Arthritis"],"prefix":"10.1007","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-2812-5147","authenticated-orcid":false,"given":"Joana","family":"Atxotegi-Saenz de Buruaga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Consuelo","family":"Modesto-Caballero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Perez-Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,25]]},"reference":[{"key":"842_CR1","first-page":"819","volume":"23","author":"F Salaffi","year":"2005","unstructured":"Salaffi F, De Angelis R, Grassi W. Prevalence of musculosketal conditions in an Italian population simple: results of a regional community-based study. I. The MAPPING study. Clin Exp Rheumatol. 2005;23:819\u201328.","journal-title":"Clin Exp Rheumatol"},{"issue":"26","key":"842_CR2","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1056\/NEJMra1511117","volume":"374","author":"AK Rosenthal","year":"2016","unstructured":"Rosenthal AK, Ryan LM. Calcium pyrophosphate deposition disease. N Engl J Med. 2016;374(26):2575\u201384.","journal-title":"N Engl J Med"},{"key":"842_CR3","first-page":"186","volume":"1","author":"J de Atxotegi-Saenz Buruaga","year":"2003","unstructured":"de Atxotegi-Saenz Buruaga J, Perez-Herrero N, Perez-Herrero N, Vazquez-Puente C, Modesto-Caballero C, Perez-Ruiz F. Association of mutations in hemochromatosis genes with clinical severity of calcium pyrophosphate arthritis. Explor Muskuloskeletal Dis. 2003;1:186\u201393.","journal-title":"Explor Muskuloskeletal Dis"},{"key":"842_CR4","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1136\/ard.2010.139105","volume":"70","author":"W Zhang","year":"2011","unstructured":"Zhang W, Doherty M, Bardin T, et al. European League Against Rheumatism recommendations for calcium pyrophosphate deposition. Part I: terminology and diagnosis. Ann Rheum Dis. 2011;70:563\u201370.","journal-title":"Ann Rheum Dis"},{"key":"842_CR5","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/0049-0172(92)90019-A","volume":"22","author":"AC Jones","year":"1992","unstructured":"Jones AC, Chuck AJ, Arie EA, Green J, Doherty M. Diseases associated with calcium pyrophosphate deposition disease. Semin Arthritis Rheum. 1992;22:188\u2013202.","journal-title":"Semin Arthritis Rheum"},{"key":"842_CR6","first-page":"2103","volume-title":"Arthitis and allied conditions: a textbook of rheumatology","author":"LM Ryan","year":"1997","unstructured":"Ryan LM, McCarty DJ. Calcium pyrophosphate crystal deposition disease, pseudogout, and articular chondrocalcinosis. In: Koopman W, editor. Arthitis and allied conditions: a textbook of rheumatology. Baltimore: Williams and Wilkins; 1997. p. 2103\u201326."},{"key":"842_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-017-1450-6","volume":"19","author":"C Zeng","year":"2017","unstructured":"Zeng C, Wei J, Terkelbaub R, et al. Dose-response relationship between lower serum magnesium level and higher prevalence of knee chondrocalcinosis. Arthritis Res Ther. 2017;19:236.","journal-title":"Arthritis Res Ther"},{"key":"842_CR8","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1002\/art.23106","volume":"57","author":"P Richette","year":"2007","unstructured":"Richette P, Ayoub G, Lahalle S, et al. Hypomagnesemia associated with chondrocalcinosis: a cross-sectional study. Arthritis Rheum. 2007;57:1496\u2013501.","journal-title":"Arthritis Rheum"},{"key":"842_CR9","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1136\/ard.62.6.513","volume":"62","author":"RL Neame","year":"2003","unstructured":"Neame RL, Carr AJ, Muir K, Doherty M. UK community prevalence of knee chondrocalcinosis: evidence that correlation with osteoarthritis is through a shared association with osteophyte. Ann Rheum Dis. 2003;62:513\u20138.","journal-title":"Ann Rheum Dis"},{"key":"842_CR10","doi-asserted-by":"publisher","first-page":"53","DOI":"10.5152\/eurjrheum.2017.16116","volume":"5","author":"A Joshi","year":"2018","unstructured":"Joshi A, Siva C. Magnesium disorders can cause calcium pyrophosphate deposition disease: a case report and literature review. Eur J Rheumatol. 2018;5:53\u20137.","journal-title":"Eur J Rheumatol"},{"key":"842_CR11","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1136\/ard-2023-224575","volume":"82","author":"A Abhishek","year":"2023","unstructured":"Abhishek A, Tedeschi S, Pascart T, et al. The 2023 ACR\/EULAR classification criteria for calcium pyrophosphate deposition disease. Ann Rheum Dis. 2023;82:1248\u201357.","journal-title":"Ann Rheum Dis"},{"key":"842_CR12","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1002\/acr.23160","volume":"69","author":"C Kleiber-Balderrama","year":"2017","unstructured":"Kleiber-Balderrama C, Rosenthal A, Lans D, Singh J, Bartels C. Calcium pyrophosphate deposition disease and associated medical comorbidities: a national cross-sectional study of US Veterans. Arthritis Care Res. 2017;69:1400\u20136.","journal-title":"Arthritis Care Res"},{"key":"842_CR13","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1093\/rheumatology\/kes204","volume":"51","author":"RY Rho","year":"2012","unstructured":"Rho RY, Zhu Y, Zhang Y, Reginato A, Choi HK. Risk factors for pseudogout in the general population. Rheumatology (Oxford). 2012;51:2070\u20134.","journal-title":"Rheumatology (Oxford)"},{"key":"842_CR14","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/S0025-7125(16)30016-5","volume":"79","author":"WB Kannel","year":"1995","unstructured":"Kannel WB, Wilson PW. An update on coronary risk factors. Med Clin North Am. 1995;79:951\u201371.","journal-title":"Med Clin North Am"},{"key":"842_CR15","doi-asserted-by":"publisher","first-page":"167","DOI":"10.2165\/00003495-198400281-00017","volume":"28","author":"MP Ryan","year":"1984","unstructured":"Ryan MP, Devane J, Ryan MF, Counihan TB. Effect of diuretics on the renal handling of magnesium. Drugs. 1984;28:167\u201381.","journal-title":"Drugs"},{"key":"842_CR16","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.2215\/CJN.09750913","volume":"10","author":"J Blaine","year":"2015","unstructured":"Blaine J, Chonchol M, Levi M. Renal control of calcium, phosphate and magnesium homeostasis. Clin J Am Soc Nephrol. 2015;10:1257\u201372.","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Rheumatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-026-00842-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40744-026-00842-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-026-00842-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T08:46:36Z","timestamp":1779525996000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40744-026-00842-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,25]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["842"],"URL":"https:\/\/doi.org\/10.1007\/s40744-026-00842-5","relation":{},"ISSN":["2198-6576","2198-6584"],"issn-type":[{"value":"2198-6576","type":"print"},{"value":"2198-6584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,25]]},"assertion":[{"value":"18 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors (Joana Atxotegi-Saenz de Buruaga, Consuelo Modesto-Caballero, Fernando Perez-Ruiz) have nothing to disclose for this topic. Fernando Perez-Ruiz is an Editorial Board member of\n                      Rheumatology and Therapy\n                      . Fernando Perez-Ruiz was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Confect of Interest"}},{"value":"This study was assessed and approved by the hospital\u2019s Ethics Committee OSI-EEC (Organizaci\u00f3n Sanitaria Integrada Ezkerraldea Enkarterri Cruces, code number E07\/15). Informed consent was obtained from each patient after being informed of the study objectives. The study was conducted in accordance with the Helsinki Declaration of 1964 and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}